KRAKOW, Poland, March 27, 2025 /PRNewswire/ -- Selvita S.A. (WSE: SLV), one of Europe's leading preclinical CROs, has announced its financial results for 2024 and provided an update on its backlog for 2025. Key Highlights: In Q4 2024, Selvita generated EUR 22.5 million in commercial...
Read More Details
Finally We wish PressBee provided you with enough information of ( Selvita Reports Rebound in H2 2024 and 11% Increase in Backlog for 2025 )
Also on site :
- Will Chicago have Fourth of July fireworks? What to know about Navy Pier schedule
- Legendary Hard Rock Band Teases Big Event With ‘Probably the Greatest Photo in Rock/ Metal History’
- Judge blocks immigrants’ deportation to South Sudan one day after Supreme Court clears the way